Digestive System Neoplasms Clinical Trials

51 clinical trials for Digestive System Neoplasms across international registries, including 11 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations — RECRUITING
• Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer — RECRUITING · PHASE3
• A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC — RECRUITING · PHASE3
• Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study — RECRUITING · NA
• EUS-guided RFA for Solid Abdominal Neoplasms — RECRUITING · NA
• Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer. — RECRUITING · PHASE2
• Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System Neoplasms — RECRUITING · PHASE1
• Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms — RECRUITING · PHASE1
• Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms — RECRUITING · PHASE1
• Spanish Series of Patients Treated With the Radionuclide Lutetium177 — RECRUITING
• Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients — RECRUITING · PHASE2
• Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery — COMPLETED · PHASE2
• Effectiveness of an Educational Intervention Aimed at Increasing the Emotional Competencies of Patients Under Surveillance After Antineoplastic Treatment of Oesogastric or Bronchopulmonary Cancer — COMPLETED · NA
• IP rmhTNF-NC + Tislelizumab + Palliat RT for GIT Tumor Malignant Ascites After Failed Std Tx — NOT_YET_RECRUITING · PHASE2
• TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC — COMPLETED · PHASE2
• 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients — COMPLETED · PHASE1
• Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer. — OTHER · NA
• Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study — ACTIVE_NOT_RECRUITING · PHASE2
• A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors — TERMINATED · PHASE2
• Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) — COMPLETED · PHASE3
• Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic Cholangiocarcinoma — OTHER · PHASE2
• Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma — COMPLETED · PHASE2
• Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients — COMPLETED · PHASE2
• Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors — COMPLETED · PHASE1
• Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases — OTHER
• Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms — OTHER · PHASE1
• Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• Observatory of the Quality of Surgical Procedures for Digestive Cancers — TERMINATED
• A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms — OTHER · PHASE1
• Early Versus Delayed Parenteral Nutrition in Abdominal Surgical Patients — COMPLETED · NA
• Gradual Versus Immediate Goal-dose Enteral Nutrition in Abdominal Surgery Patients — COMPLETED · NA
• Educational Intervention to Increase the Emotional Competence of Patients With Oesogastric and Bronchopulmonary Cancers — TERMINATED · NA
• The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer — OTHER · PHASE3
• Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C) — OTHER · PHASE2
• A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC — COMPLETED · PHASE3
• Low Rectal Cancer Study (MERCURY II) — OTHER
• Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks — OTHER · PHASE2
• Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial — OTHER
• BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities — COMPLETED · NA
• Radiomics for Prediction of Lymph Node Metastasis in Gastric Cancer（RPLNM）(GIPMCS-1701) — OTHER
• Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization — OTHER · PHASE2
• Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer — OTHER · PHASE2
• Evaluation of Predictive Visual Analog Scale (VAS) for Determining the Ingesta of Patients Carrying a Digestive Cancer — COMPLETED
• DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma — OTHER · PHASE2
• Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer — OTHER · PHASE2
• Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer — OTHER · PHASE2
• Celiac Plexus Radiosurgery for Pain Management — OTHER · PHASE2
• Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer Patients — OTHER · NA
• Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) — TERMINATED · PHASE3
• Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma — OTHER · PHASE2

Refine this search